Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms.

Baas IO, van den Berg FM, Mulder JW, Clement MJ, Slebos RJ, Hamilton SR, Offerhaus GJ
J Pathol. 1996 178 (3): 264-7

PMID: 8778330 · DOI:10.1002/(SICI)1096-9896(199603)178:3<264::AID-PATH485>3.0.CO;2-#

Immunohistochemistry (IHC) for intranuclear p53 gene product is a simple, routine alternative to molecular genetic analysis of the p53 gene. Several methods for antigen enhancement are currently in use for IHC. This study evaluates the effect of extreme antigen enhancement for p53, using a monoclonal antibody (DO7) and a polyclonal antibody (CM1). The cases studied were five colorectal carcinomas, two specimens of normal colorectal mucosa, and four colorectal carcinomas with genetic alterations which are expected to preclude p53 gene product expression, namely mutation to a STOP codon in the p53 gene detected by denaturing gradient gel electrophoresis with subsequent sequencing and allelic loss of 17p in the region where p53 is located, detected by restriction fragment length polymorphism analysis. The findings suggest that extreme antigen enhancement may cause false-positive results with a distinct nuclear staining pattern when MAb DO7 is used as a primary antibody. It is concluded that all antigen enhancement methods should be thoroughly tested to evaluate their validity and that there may be a limit to the extent to which antigen enhancement can be applied in IHC for p53 protein.

MeSH Terms (12)

Antibodies, Monoclonal Antigens Colorectal Neoplasms DNA Electrophoresis False Positive Reactions Humans Immunohistochemistry Intestinal Mucosa Microwaves Mutation Tumor Suppressor Protein p53

Connections (1)

This publication is referenced by other Labnodes entities:

Links